Please find attached for your attention, correspondence from Joe Brogan, Assistant Director of Integrated Care, Head of Pharmacy and Medicines Management.
The Department of Health (DoH) is consulting on policy proposals to implement a Duty of Candour for Health and Social Care (HSC) and are keen to hear from everyone who uses or provides services.
The DoH is hosting an online information session for pharmacists and pharmacy staff at 6pm on Monday 14 June 2021. The purpose of this event is to provide an overview of the proposals that have been published for consultation, and answer any questions that attendees may have.
Further information regarding this event can be found HERE.
Kinds regards, stay safe – Gareth
SENT ON BEHALF OFDR. GARETH C. GILVARY Governance & Support Pharmacist
Dear Colleagues,
Please find attached for your attention, weekly roundup correspondence from HSCB Pharmacy & Medicines Management.
Kinds regards, stay safe – Gareth
SENT ON BEHALF OFDR. GARETH C. GILVARY Governance & Support Pharmacist
SENT ON BEHALF OF DR. GARETH C. GILVARY Governance & Support Pharmacist
Dear Colleagues,
Please find attached for your attention, correspondence from Kathryn Turner, Pharmacy Lead, HSCB.
From today, individuals aged 25 to 29, (born between 01/05/1991 and 31/07/1996) are eligible to be vaccinated through the community pharmacy service (see cohort 12 in Appendix 1).
JCVI guidance issued on 7 April 2021 advised that it is preferable for adults aged <30 years without underlying health conditions that put them at higher risk of severe COVID-19 disease, to be offered an alternative COVID-19 vaccine, if available. In light of the limited number of appointments available each week in Trust vaccination centres for patients seeking first doses of the Pfizer vaccine, the DoH have clarified that from today individuals aged 25 to 29 years who wish to make an informed decision to receive the AstraZeneca vaccine can be vaccinated through the community pharmacy service.
Kinds regards, stay safe – Gareth
SENT ON BEHALF OFDR. GARETH C. GILVARY Governance & Support Pharmacist
Dear Colleague
The following concessionary prices have been granted for May 2021:
Drug
Pack Size
Concessionary Price
Candesartan 2mg tablets
7
£1.35
Chlorpromazine 50mg tablets
28
£15.98
Eplerenone 25mg tablets
28
£14.25
Eplerenone 50mg tablets
28
£26.30
Esomeprazole 20mg gastro-resistant tablets
28
£5.18
Etoricoxib 60mg tablets
28
£12.00
Naftidrofuryl 100mg capsules
84
£8.10
Olmesartan medoxomil 10mg tablets
28
£7.85
Olmesartan medoxomil 20mg tablets
28
£8.30
Olmesartan medoxomil 40mg tablets
28
£14.52
Pregabalin 100mg capsules
84
£6.10
Pregabalin 150mg capsules
56
£4.99
Pregabalin 200mg capsules
84
£7.00
Pregabalin 300mg capsules
56
£5.61
Pregabalin 50mg capsules
84
£6.69
Pregabalin 75mg capsules
56
£6.50
Prochlorperazine 5mg tablets
28
£1.79
Sulfasalazine 500mg gastro-resistant tablets
112
£18.79
Sulfasalazine 500mg tablets
112
£17.45
Trimethoprim 200mg tablets
6
£1.70
Trimethoprim 200mg tablets
14
£3.97
Trimethoprim 50mg/5ml oral suspension sugar free
100ml
£11.95
Zonisamide 100mg capsules
56
£49.99
This is the first update of concessionary prices for May 2021.
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Concessionary prices may be granted up until the end of the month so CPNI will notify you of any further concessionary prices as and when they are agreed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter.
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
